We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

RNA-Seq – News and Features

News

Scientists Find RNA Surprises in Listeria Bacteria

HHMI scientists studies the molecular mechanisms that transform Listeria monocytogenes from a harmless soil-dweller to a dangerous human pathogen.
News

New Genomic Technique Uncovers Coral Transcriptome

Researchers have uncovered the larval transcriptome of a reef-building coral by utilizing a new technique for cDNA preparation.
News

New Early Detection Studies of Lung Cancer in Non-Smokers Launched

Government and private sector cancer scientists have launched a research partnership to find biomarkers for lung cancer that develops in people who have never smoked.
News

Penn Scientists Use RNA to Reprogram One Cell Type into Another

Researchers try to tweak cells at the gene and nucleus level to reprogram their identity.
News

Rare Window on Spinal Muscular Atrophy Genetics

A new study detail sheds light on two distinct mechanisms at work in different forms of SMA.
News

CLC bio Bridges Digital and Analogue Gene Expression with new Version of CLC Genomics Workbench

The new version 3.0 features digital gene expression, expression analysis of micro arrays and RNA-seq data.
News

InforSense Partners with U.K.’s Leading Institutions to Combat Alzheimer’s Disease

Translational research solution to help accelerate early diagnosis and personalized medicine treatments.
News

Illumina Announces Breakthrough Human Genome Sequencing Studies Published in Nature

Three landmark studies of independent human genomes carried out on Illumina genome analyzer.
News

Exonhit Announces New Scientific Publications on the Use of SpliceArray™

Company has announced the publication of five new key scientific articles based on the use of its owned designed microarrays.
News

InnoMed PredTox Consortium Presents Final Results from Non-clinical Safety Studies

The consortium, established to improve drug safety, will meet in Basel to present conclusions from a 36-month non-clinical safety study.
Advertisement